Fluoroestradiol F-18
Fluoroestradiol F-18, also known as [18F]16α-fluoroestradiol and sold under the brand name Cerianna, is a radioactive diagnostic agent indicated for use with positron emission tomography (PET) imaging.[1][2][3][4][5] It is an analog of estrogen and is used to detect estrogen receptor-positive breast cancer lesions.[1]
![]() | |
Clinical data | |
---|---|
Trade names | Cerianna |
Other names | [18F]16α-Fluoroestradiol; [18F]16α-Fluoroestra-1,3,5(10)-triene-3,17β-diol |
License data | |
Routes of administration | Intravenous injection |
Drug class | Estrogen; Diagnostic radiopharmaceutical |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Metabolism | Liver[1] |
Excretion | Gallbladder and kidney[1] |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
Chemical and physical data | |
Formula | C18H23[18F]O2 |
Molar mass | 289.37[1] |
3D model (JSmol) | |
| |
|
Chemistry
Chemically, fluoroestradiol F-18 is [18F]16α-fluoro-3,17β-diol-estratriene-1,3,5(10).[1]
History
Fluoroestradiol F-18 was approved for medical use in the United States in May 2020.[6]
gollark: Your point?
gollark: Yes, and lyric bad.
gollark: During the baidireign.
gollark: I was mod, remember?
gollark: I have to manually run some messages through a program which messes up the spelling a bit and introduces swear words.
See also
References
- https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212155s000lbl.pdf
- Katzenellenbogen JA (February 2020). "The quest for improving the management of breast cancer by functional imaging: The discovery and development of 16α-[18F]fluoroestradiol (FES), a PET radiotracer for the estrogen receptor, a historical review". Nucl. Med. Biol. doi:10.1016/j.nucmedbio.2020.02.007. PMID 32229068.
- Evangelista L, Guarneri V, Conte PF (2016). "18F-Fluoroestradiol Positron Emission Tomography in Breast Cancer Patients: Systematic Review of the Literature & Meta-Analysis". Curr Radiopharm. 9 (3): 244–257. doi:10.2174/1874471009666161019144950. PMID 27774910.
- Liao GJ, Clark AS, Schubert EK, Mankoff DA (August 2016). "18F-Fluoroestradiol PET: Current Status and Potential Future Clinical Applications". J. Nucl. Med. 57 (8): 1269–75. doi:10.2967/jnumed.116.175596. PMID 27307345.
- Sundararajan L, Linden HM, Link JM, Krohn KA, Mankoff DA (November 2007). "18F-Fluoroestradiol". Semin Nucl Med. 37 (6): 470–6. doi:10.1053/j.semnuclmed.2007.08.003. PMID 17920354.
- "Cerianna: FDA-Approved Drugs". U.S. Food and Drug Administration (FDA). Retrieved 22 May 2020.
External links
- "Fluoroestradiol F-18". Drug Information Portal. U.S. National Library of Medicine.
- "Fluoroestradiol F-18". NCI Thesaurus. 4 May 2020.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.